Your browser doesn't support javascript.
loading
Response to the letter re: Changing treatment landscape associated with improved survival in advanced hepatocellular carcinoma: A nationwide, population-based study.
Ben Khaled, Najib; Mörtl, Bernhard; Beier, Dominik; Reiter, Florian P; Pawlowska-Phelan, Dorota; Teufel, Andreas; Rössler, Daniel; Schwade, Daniel F; Philipp, Alexander; Kubisch, Ilja; Ehmer, Ursula; Geier, Andreas; Lange, Christian M; Mayerle, Julia; Berger, Karin; De Toni, Enrico N; Munker, Stefan.
Afiliação
  • Ben Khaled N; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Institute of Molecular Oncology and Functional Genomics, School of Medicine, TU München, Muni
  • Mörtl B; Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.
  • Beier D; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
  • Reiter FP; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Pawlowska-Phelan D; InGef - Institute for Applied Health Research Berlin GmbH, Berlin, Germany.
  • Teufel A; Department of Medicine II, Division of Hepatology, Division of Bioinformatics, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany; Clinical Cooperation Unit Healthy Metabolism, Center for Preventive Medicine and Digital Health Baden-Württemberg (CPDBW), Medical Faculty Mannheim, Heid
  • Rössler D; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Schwade DF; Institute of Molecular Oncology and Functional Genomics, School of Medicine, TU München, Munich, Germany.
  • Philipp A; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Kubisch I; Department of Internal Medicine II, Gastroenterology, Hepatology, Endocrinology, Metabolic Disorders, Oncology, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
  • Ehmer U; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Internal Medicine II, Klinikum rechts der Isar, TU München, Munich, Germany.
  • Geier A; Bavarian Cancer Research Center (BZKF), Erlangen, Germany; Division of Hepatology, Department of Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Lange CM; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany.
  • Mayerle J; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Berger K; Department of Medicine III and Comprehensive Cancer Center (CCC Munich LMU), University Hospital, LMU Munich, Munich, Germany.
  • De Toni EN; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany; Bavarian Cancer Research Center (BZKF), Erlangen, Germany.
  • Munker S; Department of Medicine II, University Hospital, LMU Munich, Munich, Germany; Department of Pharmaceutical Biology, LMU Munich, Munich, Germany.
Eur J Cancer ; 198: 113499, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38160177
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2024 Tipo de documento: Article